| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 48.924 | 48.409 | 40.396 | 36.272 | 8.697 | 0 | 0 | 0 | 0 | 0 |
| Total Income - EUR | 48.924 | 48.533 | 40.396 | 36.272 | 8.697 | 0 | 0 | 0 | 0 | 0 |
| Total Expenses - EUR | 36.561 | 38.339 | 52.500 | 78.877 | 16.197 | 62 | 10 | 45 | 377 | 660 |
| Gross Profit/Loss - EUR | 12.363 | 10.194 | -12.104 | -42.604 | -7.500 | -62 | -10 | -45 | -377 | -660 |
| Net Profit/Loss - EUR | 10.895 | 9.708 | -12.508 | -42.967 | -7.587 | -62 | -10 | -45 | -377 | -660 |
| Employees | 6 | 5 | 8 | 13 | 2 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Danicris Intermed Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 38.764 | 38.360 | 37.711 | 37.019 | 36.302 | 35.614 | 34.824 | 34.932 | 34.826 | 34.632 |
| Current Assets | 8.124 | 24.301 | 21.755 | 211 | 0 | 0 | 0 | 0 | 0 | 492 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 0 | 0 | 766 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash | 8.124 | 24.301 | 20.989 | 211 | 0 | 0 | 0 | 0 | 0 | 492 |
| Shareholders Funds | 37.275 | 46.603 | 33.307 | -10.272 | -51.693 | -50.775 | -49.659 | -49.858 | -50.084 | -50.464 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 9.614 | 16.058 | 26.159 | 47.502 | 87.995 | 86.389 | 84.483 | 84.791 | 84.911 | 85.588 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "6831 - 6831" | |||||||||
| CAEN Financial Year |
6831
|
|||||||||
Comments - Danicris Intermed Srl